Pharmaceutical companies are concerned about their ability to bring more drugs to market faster due to clinical data challenges. 81% cited data governance issues as their biggest challenge in meeting regulatory compliance. Data governance is an important concern because clinical data quality issues can hinder a trial’s completion.